Skip to main content
JIUZHITANG CO.,LTD logo

JIUZHITANG CO.,LTD — Investor Relations & Filings

Ticker · 000989 ISIN · CNE000001394 LEI · 3003004OFW6FCZ34KN72 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,885 across all filing types
Latest filing 2025-03-03 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 000989

About JIUZHITANG CO.,LTD

https://www.hnjzt.com

JIUZHITANG CO.,LTD. is a pharmaceutical enterprise specializing in the research, development, manufacturing, and distribution of Traditional Chinese Medicine (TCM). Established in 1650, the company is recognized as a time-honored brand with a heritage spanning over three centuries. Its core product portfolio includes a diverse range of TCM formulations, most notably Liuwei Dihuang Wan, donkey-hide gelatin (Ejiao), and various health supplements focused on chronic disease management and general wellness. The company operates modern production facilities that integrate traditional processing techniques with contemporary scientific standards and biotechnology. JIUZHITANG focuses on the modernization of TCM through clinical research and innovation, maintaining a distribution network that serves retail pharmacies and medical institutions to provide natural healthcare solutions.

Recent filings

Filing Released Lang Actions
关于股份回购进展的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the progress of a share repurchase (buyback) program by 九芝堂股份有限公司. It details the share repurchase plan, the amount and price limits, the progress of shares repurchased up to a certain date, and compliance with regulatory requirements. The document does not contain financial statements or detailed financial analysis but focuses on the update of the share buyback activity. According to the filing definitions, this fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back or selling its own shares. The document length is 1692 characters, which is consistent with an announcement rather than a full report. Therefore, the correct classification is POS with high confidence.
2025-03-03 Chinese
关于全资子公司研发新药获得临床试验批准的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about its wholly-owned subsidiary receiving approval from the national drug regulatory authority to conduct Phase II clinical trials for a new drug. It details the drug's clinical trial approval, the drug's characteristics, the clinical trial phases, market context, and risk warnings. The document is a regulatory announcement about a clinical trial approval, not a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial data. It is a regulatory announcement about a significant development related to the company's drug development pipeline. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-02-05 Chinese
关于股份回购进展的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the progress of a share repurchase (stock buyback) program by 九芝堂股份有限公司. It details the approved repurchase plan, the amount and price limits, the progress of shares repurchased up to a certain date, and compliance with regulatory requirements. The document does not contain financial statements or detailed financial analysis but focuses on the update of the share repurchase activity. According to the filing definitions, reports about the company buying back its own shares fall under 'Transaction in Own Shares' (POS). The document length is 1690 characters, which is consistent with an announcement rather than a full report. Therefore, the correct classification is POS with high confidence.
2025-02-05 Chinese
关于大股东部分股份解除质押及股份协议转让过户完成暨公司控制权发生变更的公告
Major Shareholding Notification Classification · 100% confidence The document is an official announcement regarding the transfer of shares by a major shareholder, the completion of share pledge release, and the resulting change in company control. It details the share transfer agreement, shareholding percentages before and after the transfer, pledge release information, and regulatory approvals. The content focuses on changes in major shareholding and control, with no financial statements or earnings data. This fits the definition of a Major Shareholding Notification (MRQ) as it reports changes in significant share ownership levels and control of the company.
2025-01-13 Chinese
关于股份回购进展的公告
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from 九芝堂股份有限公司 regarding the progress of its share repurchase program. It details the share buyback plan, including the number of shares repurchased, prices, and compliance with regulatory requirements. The text explicitly mentions the repurchase of shares using company funds, the timeline, and regulatory adherence. There are no financial statements or comprehensive financial data presented, only an update on the share repurchase activity. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback of its own shares.
2025-01-02 Chinese
关于大股东签署《股份转让协议之补充协议》暨控制权拟发生变更的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a supplemental agreement to a share transfer agreement involving a major shareholder and a change in control of the company. It details the share transfer terms, approval status, and risk warnings. There are no financial statements, earnings data, or detailed financial analysis present. The document is relatively short (2072 characters) and serves as a progress update on a capital transaction involving share ownership and control change. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as share transfers and control changes.
2024-12-25 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.